Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients: Table 1-Reference-Cited by-同舟云学术

Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients: Table 1

Published:2014-04-03 Issue:10 Volume:85 Page:1177-1178
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Hoepner R,Ahlbrecht J,Faissner S,Schneider R,Dahlhaus S,Adams O,Raab P,Lukas C,Chan A,Stangel M,Gold R

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference5 articles.

1. Progressive Multifocal Leukoencephalopathy in AIDS: Are There Any MR Findings Useful to Patient Management and Predictive of Patient Survival?;Post;Am J Neuroradiol,1999

2. Progressive multifocal leucoencephalopathy. Observation with predominant pontocerebellar lesions and association with congenital immune deficiency;Gagne;Acta Neuropathol,1977

3. Cerebellar Form of Progressive Multifocal Leukoencephalopathy in a Patient with Chronic Renal Failure;Irie;Intern Med,1992

4. Disease course and outcome of 15 monocentrically treated natalizumab-associated-progressive multifocal leukoencephalopathy patients;Dahlhaus;J Neurol Neurosurg Psychiatry,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations;Multiple Sclerosis and Related Disorders;2023-09

2. Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world;Expert Opinion on Drug Safety;2023-06-10

3. Progressive multifokale Leukenzephalopathie – ein Update;DGNeurologie;2020-08-11

4. The spectrum of progressive multifocal leukoencephalopathy: a practical approach;European Journal of Neurology;2019-02-08

5. Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy;Multiple Sclerosis Journal;2016-09-06